A Phase 1, Open-Label Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females
Latest Information Update: 17 Jul 2024
At a glance
- Drugs Povorcitinib (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Asthma; Chronic urticaria; Hidradenitis suppurativa; Prurigo nodularis; Skin disorders; Vitiligo
- Focus Pharmacokinetics
- Sponsors Incyte Corporation
Most Recent Events
- 02 Jul 2024 Status changed from active, no longer recruiting to completed.
- 11 Jun 2024 Status changed from recruiting to active, no longer recruiting.
- 25 Apr 2024 New trial record